Wall Street Journal |
Intarcia's Diabetes Treatment Clears Key Test
Wall Street Journal The results build on earlier trials to suggest that the once-a-year treatment could be an important option in the sprawling diabetes market. Two studies presented in June at the American Diabetes Association meeting in Boston showed the pump achieved … This startup may have just revolutionized Type 2 diabetes treatmentFortune Hayward-made diabetes treatment beats $6B Merck drug in head-to-head trialSan Francisco Business Times (blog) Intarcia's diabetes–treating implant tops Januvia in a head-to-head testFierceBiotech NH Voice –PR Newswire (press release) –BioPharma Dive all 22 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.